Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: Implications for long-term neoplastic risk following RYGB

Gut

Volumn 60, Issue 7, 2011, Pages 893-901

  Kant, Prashant ^a   Sainsbury, Anita ^a   Reed, Karen R ^b   Pollard, Stephen G ^a   Scott, Nigel ^a   Clarke, Alan R ^b   Coletta, P Louise ^a   Hull, Mark A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ANIMAL CELL; ARTICLE; CANCER RISK; CELL MIGRATION; CELL PROLIFERATION; CELL SIZE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CRYPT CELL; ENZYME REGULATION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MITOSIS; MORBID OBESITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; ROUX Y ANASTOMOSIS;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOSIS; OBESITY, MORBID; POSTOPERATIVE PERIOD; RECTUM; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 79958209060     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.230755     Document Type: Article

References (32)

1. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78. (Pubitemid 351232031)
2. Sato Y, Nozaki R, Yamada K, et al. Relation between obesity and adenomatous polyps of the large bowel. Dig Endosc 2009;21:154-7.
3. Kim S-E, Shim K-N, Jung SA, et al. An association between obesity and the prevalence of colonic adenoma according to age and gender. J Gastroenterol 2007;42:616-23. (Pubitemid 47278686)
4. Yamaji Y, Okamoto M, Yoshida H, et al. The effect of body weight reduction on the incidence of colorectal adenoma. Am J Gastroenterol 2008;103:2061-7.
5. Jacobs ET, Ahnen DJ, Ashbeck EL, et al. Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol 2009;169:657-66.
6. Zaninotto P, Head J, Stamatakis E, et al. Trends in obesity among adults in England from 1993 to 2004 by age and social class and projections of prevalence to 2012. J Epidemiol Commun Health 2009;63:140-6.
7. Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006;55:285-91. (Pubitemid 43117290)
8. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-19.
9. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
10. Terzic J, Grivennikov S, Karin E, et al. Inflammation and colon cancer. Gastroenterology 2010;138:2101-14.
11. Sainsbury A, Goodlad RA, Perry SL, et al. Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass. Cancer Epidemiol Biomarkers Prev 2008;17:1401-10.
12. Wilson JM, Coletta PL, Cuthbert RJ, et al. Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 2005;129:1485-503. (Pubitemid 41597391)
13. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003;3:791-800. (Pubitemid 37328657)
14. Sansom OJ, Mansergh FC, Evans MJ, et al. Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice. Gut 2007;56:1410-14. (Pubitemid 47517836)
15. Sansom OJ, Reed KR, Hayes AJ, et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 2004;18:1385-90. (Pubitemid 38780625)
16. Deitel M, Greenstein R. Recommendations for reporting weight loss. Obes Surg 2003;13:159-60. (Pubitemid 36609534)
17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-(Delta)(Delta)CT Method. Methods 2001;25:402-8. (Pubitemid 34164012)
18. Maaser C, Eckmann L, Paesold G, et al. Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium. Gastroenterology 2002;122:667-80. (Pubitemid 34173819)
19. Larson D, Horak K. Macrophage migration inhibitory factor: controller of systemic inflammation. Crit Care 2006;10:138.
20. Hull MA. Bile acids and colorectal cancer. In: Jenkins G, Hardie L, eds. Bile Acids: Toxicology and Bioactivity. RSC Publishing, 2008:84-99.
21. Xia HH, Zhang ST, Lam SK, et al. Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs. Carcinogenesis 2005;26:11-15. (Pubitemid 40207694)
22. Bostick RM, Fosdick L, Lillemoe TJ, et al. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans. Cancer Epidemiol Biomarkers Prev 1997;6:931-42. (Pubitemid 27481642)
23. Mills SJ, Mathers JC, Chapman PD, et al. Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis. Gut 2001;48:41-6. (Pubitemid 32042640)
24. Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity 2009;17:796-802.
25. Christou NV, Lieberman M, Sampalis F, et al. Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obesity Rel Dis 2008;4:691-5.
26. Östlund MP, Lu Y, Lagergren J. Risk of obesity-related cancer after obesity surgery in a population-based cohort study. Ann Surg 2010;252:972-6.
27. Sansom OJ, Meniel VS, Muncan V, et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 2007;446:676-9. (Pubitemid 46606884)
28. Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009;106:2365-70.
29. Ohkawara T, Nishihira J, Takeda H, et al. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 2002;123:256-70. (Pubitemid 34747546)
30. Petrenko O, Fingerle-Rowson G, Peng T, et al. Macrophage migration inhibitory factor deficiency is associated with altered cell growth and reduced susceptibility to Ras-mediated transformation. J Biol Chem 2003;278:11078-85. (Pubitemid 36792659)
31. Maharshak N, Cohen S, Lantner F, et al. CD74 is a survival receptor on colon epithelial cells. World J Gastroenterol 2010;16:3258-66.
32. Ouertatani-Sakouhi H, El-Turk F, Fauvet B, et al. Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action. J Biol Chem 2010;285:26581-98.